Ahmed Irchad

Dr. Ahmed Irchad


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HMHidaya Mansouri
Hidaya Mansouri
AIAhmed Irchad
Ahmed Irchad
CRClarence Rubaka
Clarence Rubaka
LKLydia Kisula
Lydia Kisula
AHAbdou Azali Hamza
Abdou Azali Hamza
ESElingarami Sauli
Elingarami Sauli
Breast cancer remains a major global health challenge despite advances in chemotherapy, endocrine therapy, targeted therapy, and radiotherapy, which are frequently constrained by therapeutic resistance, cumulative toxicity, and high costs. Accumulating preclinical and translational evidence demonstrates that plant-derived natural compounds can synergistically enhance the efficacy of conventional treatments, improve tumor response, and potentially reduce adverse effects. This review critically synthesizes in vitro, in vivo, and emerging clinical studies from 2015 to 2025, focusing on key phytochemicals, including curcumin, epigallocatechin-3-gallate, resveratrol, kaempferol, genistein, and other bioactive molecules as stand alone agents and as mechanistically validated adjuvants to chemotherapy, hormonal therapy, and radiotherapy. These compounds exert complementary actions, including the inhibition of PI3K/Akt/mTOR and NF-κB signaling, induction of apoptosis and cell-cycle arrest, suppression of epithelial–mesenchymal transition, and modulation of drug resistance pathways. Preclinical studies consistently show that combination strategies enhance tumor inhibition and may permit cytotoxic dose reduction, mitigating systemic and cardiotoxic effects. Nanocarrier-based delivery systems further optimize solubility, bioavailability, and tumor targeting. Despite robust preclinical evidence, clinical translation is limited by variability in raw materials, lack of standardization, regulatory barriers, and scarce large-scale trials. This review emphasizes both the therapeutic promise and translational challenges of integrating natural compounds as synergistic adjuvants in evidence-based breast cancer therapy.

23 January 2026 in International Journal of Science and Social Science Research
Verified
Journal Article
Open access
PDF file
YTYssoufa Thabiti
Yssoufa Thabiti
FMFatima Zahra Moussaid
Fatima Zahra Moussaid
AIAhmed Irchad
Ahmed Irchad
The asymmetric transmission of oil price fluctuations into food inflation in Small Island Developing States (SIDS) remains insufficiently explored, despite its importance for price stability and economic resilience. This study addresses this gap by focusing on the Comoros, an import-dependent island economy where exposure to external shocks is structurally amplified. Using a Nonlinear Autoregressive Distributed Lag (NARDL) framework complemented by Quantile Regression from 2000 to 2024, we uncover the complex dynamics linking oil prices, exchange rate movements, GDP per capita growth, and food inflation. The results show clear short-run asymmetries: positive oil price shocks significantly raise food inflation (β = 12.74, p < 0.01), while negative shocks produce an even stronger deflationary effect (β = –22.10, p < 0.01), confirming a pronounced “rocket and feather” pattern. Exchange rate depreciation emerges as the dominant driver of short-run inflation (β = 56.98, p < 0.001), while improved economic conditions exert a mild stabilizing effect (β = –1.23, p < 0.05). The error correction term (–0.91) indicates rapid adjustment toward long-run equilibrium. Quantile estimates reveal that oil price shocks intensify during high-inflation regimes (90th), whereas exchange rate shocks are most destabilizing during low-inflation(50th) periods, highlighting substantial distributional heterogeneity. These findings offer critical insights for policymakers in SIDS seeking to design targeted, shock-responsive inflation management strategies.